Signal A trillion-dollar drugmaker builds a discovery supercomputer with a chip vendor
Summary
CB Insights reports the pharmaceutical company it ranked first on its own AI readiness index partnering with a chip maker to build a supercomputer for drug discovery, with the company's chief AI officer describing AI moving from tool to scientific collaborator.
Classification
Main topicBio & Health Tech
Region menusGlobal
Occurrencescope:country · geo_region:north_america · country:US
Impactscope:global
Time horizon0-3 years (2026-07-26)
Last updated2026-07-29 04:49:52
Evidence 3
- 2026 Tech Trends CB Insights page=49;section=Health & bio / Pharma's path to self-driving labs 2026-01 accessed 2026-07-26
- 2026 Tech Trends CB Insights page=49;section=Health & bio / Pharma's path to self-driving labs 2026-01 accessed 2026-07-26
- 2026 Tech Trends CB Insights page=49;section=Health & bio / Pharma's path to self-driving labs 2026-01 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-4c5e732cc755